Optimising the dose of capecitabine in metastatic breast cancer: confused, clarified or confirmed?
Zielinski
C
C
Department of Medicine I and Clinical Division of Oncology, Medical University of Vienna, Vienna; Central European Cooperative Oncology Group (CECOG), Vienna, Austria. Electronic address: christoph.zielinski@meduniwien.ac.at.
Gralow
J
J
Department of Medicine, University of Washington, Seattle, WA, USA.
Martin
M
M
Medical Oncology Department, Hospital Clinico San Carlos, Madrid, Spain.